BETA: Please send your feedback!
Alpha & Omega Semiconductor
AOSL:NAS
Semiconductors
$298.13mm
SMALL cap
$12.16
(-0.63%)
0.16%
since start of 2019
159.58
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 2
-
CF
-
PP
-
WC
-
DP
-
CH
-
ES
-
WS
-
CG
-
EP
-
CM
-
FL
-
GD
- —
- 1
- 2
- 3
- 4
- 5
About
Biotechnology
Founded 1999
NewLink Genetics Corp. is a clinical stage immuno-oncology company, which focuses on discovering, developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians. Its portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. The company's products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189 and IDO Pathway Inhibitors. NewLink Genetics was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA.
website
Headquarters
Executives
| Name | Title | Gender |
| Mike F. Chang, PhD | Chairman & Chief Executive Officer | Male |
| Yueh-Se Ho, PhD | Chief Operating Officer & Director | Male |
| Yi Fan Liang, CPA | CFO, Secretary & Principal Accounting Officer | Male |
| Anup Bhalla, PhD | Founder | Male |
| So-Yeon Jeong | Head-Investor Relations | Female |
| Sik Kwong Lui, PhD | Vice President-Silicon Technology | Male |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
-
Carbon Footprint — N/A
-
Pollution Prevention — N/A
-
Water Conservation — N/A
-
Data & Privacy Protection — N/A
-
Consumer Health, Wellness & Safety — N/A
-
Employee Ownership, Satisfaction, Benefits & Pay — N/A
-
Workplace Health and Safety — N/A
-
Integrity of Corporate Governance — N/A
-
Ethical Practices — N/A
-
Usage of Conflict Materials — N/A
-
Forced Labor — N/A
-
Diversity of Corporate Leadership 2
NewLink Genetics - Competitors and Related Companies
How NewLink Genetics stacks up to its peers in the Biotechnology industry or with competing business segments.
NewLink Genetics
NLNK:NAS
Biotechnology
$59.14mm
SMALL cap
$1.58
(-0.17%)
-0.04%
since start of 2019
-1.55
Loading…